Cut red tape and increase access to substance abuse treatment for the most vulnerable in the opioid epidemic, including babies born addicted.

Michael R. Turner · Ohio · Republican

policy impact 0.82 specificity 0.88 extraction confidence 97%

Occurrences

Pushing to cut red tape and increase access to substance abuse treatment for the most vulnerable in the opioid epidemic, including babies born addicted

Commits to reducing regulatory barriers and expanding treatment access for opioid-affected people, including addicted newborns.

Mike Turner
campaign · campaign_site · model gpt-5.4-mini

Turner has authored and is pushing for legislative fixes to increase access to substance abuse treatment for those most vulnerable in the opioid epidemic, including babies born addicted.

He says he is pushing legislation to expand access to substance abuse treatment for vulnerable people affected by the opioid epidemic.

Mike Turner | Issues
campaign · campaign_site · model gpt-5.4-mini

Evidence

Turner said the TREAT Act would 'eliminate these barriers and expand access to the resources used in treating individuals suffering from substance abuse disorders' and was designed to increase flexibility in how federal funding could be used to combat the heroin epidemic.

Shows Turner publicly embraced the exact 'cut red tape' treatment-access objective for substance abuse care.

partial same_term A for effort

Turner introduces bipartisan Legislation to Cut Red Tape for Substance Abuse Treatment
secondary · model gpt-5.4-mini · confidence 93%

Turner introduced the CRIB Act to help cover treatment costs for neonatal abstinence syndrome, saying he was 'proud to lead this effort in the House and fight for those who are born addicted to opioids.'

Direct evidence that Turner advanced a concrete bill for babies born addicted / neonatal abstinence syndrome.

partial same_term A for effort

TURNER Introduces CRIB Act
secondary · model gpt-5.4-mini · confidence 96%

Section 1007 of the enrolled SUPPORT Act is titled 'CARING RECOVERY FOR INFANTS AND BABIES' and creates Medicaid coverage options for residential pediatric recovery centers for infants with neonatal abstinence syndrome.

Turner's CRIB concept was enacted into law as part of the SUPPORT Act, showing delivery on the newborn-treatment part of the promise.

delivered same_term

H.R. 6 Enrolled Bill, SUPPORT for Patients and Communities Act
secondary · model gpt-5.4-mini · confidence 94%

Turner said the MAT Act would allow physicians to prescribe buprenorphine without first obtaining a waiver and that the bill would 'eliminate the waiver requirement' to streamline care.

Shows Turner continued pushing a concrete deregulatory treatment-access bill that matched the promise's 'cut red tape' theme.

partial later_term A for effort

Rep. Turner's Mainstreaming Addiction Treatment (MAT) Act Passes the House
secondary · model gpt-5.4-mini · confidence 90%

The notice states that amendments made by section 1262 of the Consolidated Appropriations Act, 2023 'removed' the prior waiver requirements for prescribing buprenorphine for opioid use disorder.

Official confirmation that the MAT Act policy was enacted through federal law, delivering the broader treatment-access part of the promise.

delivered later_term

Federal Register, Vol. 88, No. 29
secondary · model gpt-5.4-mini · confidence 88%

Assessments

delivered later_term

Turner materially advanced both parts of the promise in federal office. The newborn-treatment component was delivered in the same term when the SUPPORT Act enacted the CRIB Act concept for Medicaid coverage of residential pediatric recovery centers for infants with neonatal abstinence syndrome. The broader red-tape/treatment-access component was delivered later through enactment of the MAT Act policy removing the buprenorphine waiver requirement, and the evidence shows Turner sponsored and continued pushing that deregulatory access measure before passage. Because the promise covered both babies born addicted and broader access to substance abuse treatment, and both outcomes were enacted with identifiable Turner contribution, this counts as delivered with later_term timing for the full combined promise.

provider codex_cli · model gpt-5.5 · confidence 90%

delivered later_term

The promise had two main components: reducing barriers to substance-abuse treatment access and addressing care for babies born with opioid-related neonatal abstinence syndrome. The newborn-treatment component was delivered in the same term through the SUPPORT Act's CRIB-related Medicaid coverage option for residential pediatric recovery centers. The broader red-tape/treatment-access component was later delivered when the Consolidated Appropriations Act, 2023 removed the federal waiver requirement for prescribing buprenorphine for opioid use disorder, matching Turner's MAT Act objective. Because the promised outcomes were enacted, this is delivered rather than merely an effort case.

provider codex_cli · model gpt-5.5 · confidence 90%